Company Profile:
          Is ZYDUS TAKEDA HEALTHCARE PVT LTD a factory or a trader?
ZYDUS TAKEDA HEALTHCARE PVT LTD is a pharmaceutical company that primarily focuses on the marketing, sales, and distribution of innovative medicines in India. It is a joint venture between Zydus Lifesciences (India) and Takeda Pharmaceutical Company (Japan).
While the joint venture itself may not directly own and operate a manufacturing plant under its specific name, it is fundamentally a pharmaceutical company. Its parent companies, Zydus Lifesciences and Takeda Pharmaceutical Company, are both major global manufacturers of pharmaceutical products. Therefore, ZYDUS TAKEDA HEALTHCARE PVT LTD functions as a commercial arm or partner that brings manufactured drugs from its parent companies to the Indian market, particularly focusing on specialized therapeutic areas. It is part of the integrated value chain of pharmaceutical manufacturing and commercialization, rather than being a general trader of unrelated goods.
Company Introduction:
Nature of Business: Pharmaceutical Company, Joint Venture
Ownership: This entity is a strategic collaboration between Zydus Lifesciences, a leading Indian pharmaceutical company, and Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.
Focus Areas: ZYDUS TAKEDA HEALTHCARE PVT LTD is dedicated to making innovative and specialized medicines available to patients in India. Its core focus lies in critical and challenging therapeutic areas, most notably oncology (cancer treatment) and rare diseases.
Mission and Operations: The primary objective of this joint venture is to leverage Takeda's global portfolio of advanced pharmaceutical products and Zydus' deep understanding and strong presence in the Indian healthcare market. The company is responsible for the commercialization, promotion, and distribution of Takeda's innovative product pipeline within India. Its operations aim to enhance patient access to transformative medicines, address unmet medical needs, and contribute to the overall improvement of healthcare outcomes in the country. It combines Takeda's global research and development expertise with Zydus' robust commercial capabilities in India.
       
              
          Enterprise Products
          Here are some of the products manufactured or marketed by ZYDUS TAKEDA HEALTHCARE PVT LTD in India:
*   Pantoprazole
*   Rabeprazole
*   Esomeprazole
*   Dexlansoprazole
*   Levocetirizine
*   Montelukast
*   Olmesartan
*   Telmisartan
*   Atorvastatin
*   Rosuvastatin
*   Fenofibrate
*   Metformin
*   Sitagliptin
*   Voglibose
*   Gliclazide
*   Amoxycillin
*   Cefixime
*   Azithromycin
*   Ciprofloxacin